Today, Recent Investment Analysts’ Ratings Changes for Flex Pharma (FLKS)

Today, Recent Investment Analysts’ Ratings Changes for Flex Pharma (FLKS)
Flex Pharma (NASDAQ: FLKS) recently received a number of ratings updates from brokerages and research firms:

Shares of Flex Pharma Inc. (NASDAQ:FLKS) opened at 6.68 on Friday. The company has a 50-day moving average of $7.09 and a 200 day moving average of $10.28. The company’s market cap is $110.42 million. Flex Pharma Inc. has a 12 month low of $4.55 and a 12 month high of $13.97.

Flex Pharma (NASDAQ:FLKS) last released its quarterly earnings data on Wednesday, November 2nd. The biotechnology company reported ($0.65) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.72) by $0.07. On average, analysts anticipate that Flex Pharma Inc. will post ($2.54) earnings per share for the current year.

Related posts

Leave a Comment